Bank of Nova Scotia’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.11M | Sell |
9,643
-8,917
| -48% | -$1.95M | ﹤0.01% | 665 |
|
2025
Q1 | $4.16M | Sell |
18,560
-51,740
| -74% | -$11.6M | 0.01% | 493 |
|
2024
Q4 | $23M | Buy |
70,300
+61,004
| +656% | +$20M | 0.04% | 266 |
|
2024
Q3 | $2.79M | Buy |
9,296
+1,695
| +22% | +$509K | 0.01% | 582 |
|
2024
Q2 | $2.5M | Sell |
7,601
-1,583
| -17% | -$521K | ﹤0.01% | 594 |
|
2024
Q1 | $3.63M | Sell |
9,184
-10,871
| -54% | -$4.3M | 0.01% | 551 |
|
2023
Q4 | $7.06M | Sell |
20,055
-11,697
| -37% | -$4.12M | 0.01% | 462 |
|
2023
Q3 | $11.9M | Buy |
31,752
+25,704
| +425% | +$9.64M | 0.03% | 294 |
|
2023
Q2 | $2.31M | Buy |
6,048
+930
| +18% | +$356K | 0.01% | 501 |
|
2023
Q1 | $1.77M | Sell |
5,118
-1,000
| -16% | -$346K | 0.01% | 570 |
|
2022
Q4 | $1.44M | Sell |
6,118
-32
| -0.5% | -$7.53K | ﹤0.01% | 729 |
|
2022
Q3 | $1.51M | Sell |
6,150
-8,350
| -58% | -$2.05M | ﹤0.01% | 709 |
|
2022
Q2 | $4.36M | Buy |
14,500
+4,778
| +49% | +$1.44M | 0.01% | 513 |
|
2022
Q1 | $3.99M | Sell |
9,722
-28,485
| -75% | -$11.7M | 0.01% | 640 |
|
2021
Q4 | $17.9M | Buy |
38,207
+5,135
| +16% | +$2.41M | 0.03% | 384 |
|
2021
Q3 | $14M | Buy |
33,072
+6,724
| +26% | +$2.85M | 0.02% | 386 |
|
2021
Q2 | $9.46M | Buy |
26,348
+1,151
| +5% | +$413K | 0.02% | 436 |
|
2021
Q1 | $7.1M | Sell |
25,197
-20,137
| -44% | -$5.67M | 0.01% | 482 |
|
2020
Q4 | $12.8M | Buy |
45,334
+6,939
| +18% | +$1.97M | 0.03% | 325 |
|
2020
Q3 | $10.6M | Sell |
38,395
-30,508
| -44% | -$8.39M | 0.03% | 331 |
|
2020
Q2 | $15.7M | Buy |
68,903
+30,401
| +79% | +$6.91M | 0.05% | 239 |
|
2020
Q1 | $5.86M | Buy |
+38,502
| New | +$5.86M | 0.02% | 393 |
|
2019
Q4 | – | Sell |
-13,912
| Closed | -$1.97M | – | 984 |
|
2019
Q3 | $1.97M | Buy |
+13,912
| New | +$1.97M | 0.01% | 669 |
|
2019
Q1 | – | Sell |
-43,000
| Closed | -$4.22M | – | 906 |
|
2018
Q4 | $4.22M | Buy |
43,000
+2
| +0% | +$196 | 0.02% | 427 |
|
2018
Q3 | $5.31M | Buy |
+42,998
| New | +$5.31M | 0.02% | 412 |
|